12.01.25 -- STREAM Edition: Lessons In Scaling Regenerative Medicine Manufacturing

Explore how Process Analytical Technology accelerates novel conjugate development and how PAT is integrated with an ADC platform to enhance efficiency, data quality, and product consistency.

Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success.

Accelerate your biopharmaceutical program with a flexible, global manufacturing partner that minimizes risk, shortens timelines, and empowers seamless scaling from clinical to commercial production.

 

Our Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

Better Biopharma Host Tyler Menichiello is joined by Patrick Bilbo, chief operating officer at Organogenesis, a regenerative medicine company developing and manufacturing advanced wound care products.

Overcome binding capacity limitations in mAb purification. A new hydrogel membrane enhances productivity 30x over resins, offering superior loading capacity and consistent, scalable impurity removal.

Optimize tablet compression by simplifying calibration, speeding up changeovers, and utilizing advanced laser inspection to prevent critical punch tip wear and maintain quality.